# Where Next for Lp(a)?

Source: [JAMA Current Issue](https://jamanetwork.com/journals/jama/fullarticle/2855636) · 2026-11-10 · Medicine
Page: https://themorning.science/story/where-next-for-lp-a-48c9ba4c501a13cc
Kind: research · Impact: medium

## In brief

- The Lp(a)HORIZON trial reported top-line results on lipoprotein(a) lowering and major adverse cardiovascular events.
- JAMA Medical News covers the trial results and asks what comes next for Lp(a)-focused research and treatment.
- The source is a single JAMA Current Issue article; no further trial details are provided in the sources.

## Why it matters

Lp(a) is a genetically determined cardiovascular risk factor, and results from a large outcomes trial show whether lowering it reduces cardiovascular events, which bears on how science readers interpret future Lp(a) research.

## Timeline

- 2026-11-10: JAMA Current Issue publishes Medical News article 'Where Next for Lp(a)?' on Lp(a)HORIZON top-line results

## Coverage

- [Where Next for Lp(a)?](https://jamanetwork.com/journals/jama/fullarticle/2855636) — JAMA Current Issue, 2026-11-10

Tags: lipoprotein(a), cardiovascular, clinical trial, lipids, heart disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science